Investor profile
Eventide Asset Management has backed 2 European tech companies across 3 funding rounds between 2020 and 2022, joining rounds totalling €306M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Freeline Therapeutics | UK | 2 | €178M |
| Vectivbio | Switzerland | 1 | €127M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Vectivbio | Other | €127M | 2022-10 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Freeline Therapeutics | Series C | €71M | 2020-07 |
